Interstitial Lung Disease Alerts This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Imbruvica (ibrutinib)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) June 2016 ADVERSE REACTIONS Postmarketing Experience (Addition) Respiratory disorders: interstitial lung disease (includes... (Source: Drugs.com - Labeling Changes)
Source: Drugs.com - Labeling Changes - June 1, 2016 Category: Drugs & Pharmacology Source Type: alerts

Effexor XR (venlafaxine Extended-Release) Capsules
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) February 2016 ADVERSE REACTIONS Post-Marketing Experience Dyspnea interstitial lung disease July 2014 ... (Source: Drugs.com - Labeling Changes)
Source: Drugs.com - Labeling Changes - February 1, 2016 Category: Drugs & Pharmacology Source Type: alerts

Rapamune (sirolimus) Oral Solution and Tablets
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) November 2015 WARNINGS AND PRECAUTIONS Interstitial Lung Disease/Non-Infectious Pneumonitis In some cases, the ILD was reported... (Source: Drugs.com - Labeling Changes)
Source: Drugs.com - Labeling Changes - November 1, 2015 Category: Drugs & Pharmacology Source Type: alerts